With weight loss drugs taking the world by storm, more people are exploring adding these medical marvels to their toolkits.

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

A University of Oxford study published in The BMJ finds users of GLP-1 drugs like Ozempic regain weight and reverse heart ...

GLP-1 medications can create opportunity for change—but environment determines what lasts. Discover how context shapes habits ...

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

GLP-1 weight-loss pills appear to be just as effective as injections, with clinical trials showing similar average weight ...

As many as 12% of Americans are currently using GLP-1 medications such as Ozempic and Wegovy, according to one estimate.

You’ve likely heard of diabetes, a chronic condition that affects how the body regulates blood sugar. But are you familiar ...

As the GLP-1 trend expands, a 'halo effect' is developing. Consumers in families of GLP-1 users are increasingly eating GLP-1 ...

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

Next gen weight-loss medications are powerful — but eating too little can put some patients at serious nutritional risk.

As GLP-1 medications normalize smaller appetites and higher protein intake, national restaurant chains are quietly ...